News

Latest news

Hide mandatory notifications of trade

Mandatory Notification of Trade

Lars Høie has on 19 September 2016 disposed of 20,000,000 subscription rights obtained in connection with the rights offering in Bionor Pharma ASA (the "Company").

BIONOR PHARMA

STOCK EXCHANGE ANNOUNCEMENT

After the transaction Lars Høie holds 97,699,303 subscription rights. Lars Høie also holds 50,253,370 shares equivalent to 5.84% of the issued shares of the Company. Lars Høie further owns 15,253,370 warrants in the Company. His total holding of shares and warrants equals 7.61%, and his total holding of shares, warrants and subscription rights equals 18.96%, based on the registered share capital as of today.

This information is subject to the disclosure requirements set out in section 4-3 of the Norwegian Securities Trading Act.

Link to announcement in pdf